Quebec Consortium for Drug Discovery launched

Guest Contributor
June 20, 2008

A new Quebec Consortium for Drug Discovery has been announced at Bio 2008 in San Diego. The public private partnership has received $7 million in commitments in its first year of operation and will be headed by Max Fehlmann. Pfizer Canada, AstraZeneca Canada and Merck Frosst Canada have each committed $1 million in the first year while Pfizer and AstraZeneca have made a commitment of $4 million over the next four years. The Quebec Ministry of Economic Development and Export Trade and the Fonds de la recherché en santé du Québec are together providing $4 million. The aim of the consortium is to pool expertise in all sectors and focus on the pre-competitive stages of drug development. Funding of joint research between companies and universities is a primary objective, as is the development of tools adapted to the development of safer and more effective drugs. Researchers will submit projects aimed at accelerating the drug development process and a strategic steering committee will select those to be funded….


Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.